[go: up one dir, main page]

WO2011024039A1 - Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives - Google Patents

Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives Download PDF

Info

Publication number
WO2011024039A1
WO2011024039A1 PCT/IB2010/001886 IB2010001886W WO2011024039A1 WO 2011024039 A1 WO2011024039 A1 WO 2011024039A1 IB 2010001886 W IB2010001886 W IB 2010001886W WO 2011024039 A1 WO2011024039 A1 WO 2011024039A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
product
scheme
ethyl
potassium carbonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2010/001886
Other languages
French (fr)
Inventor
Ramesh Babu Potluri
Hari Prasad Kodali
Srinivasa Rao Venturi
Venkata Srihari Tadimalla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2011024039A1 publication Critical patent/WO2011024039A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Definitions

  • An obji»ctive ⁇ Ftl ie present Invention is to develop commercially viable methods for the synthesis of 5- [(2-ph ⁇ yisulf m) )ethyl]-lH-lndole of formula II,
  • R 1 and R 2 arc the same Q ⁇ different and each independently
  • Another!I biij j,efetife of the present invention is to convert the product formula Il to formula I in high yields.
  • R 1 and R 2 arc the same or different and each independently represent a hydrogen, fluorine, or diflower alkyl)amtflo, acyi, or alkoxy caibonyl or chlorine atom, or a lower atkyl, lower alkoxy, nitro.
  • rya ⁇ , ⁇ minol ⁇ wer alkylamine group
  • R 5 is Acetyl, propyl, trlfluoacetyt,
  • inorganic base is selected from the group consisting sod liiuu ⁇ il cirbo , potassium carbonate or cesium carbonate and the organic base is selected from the gro uupp to ⁇ s iiisstti ig of triethylamine, diisopropytethylamine, N-meth ⁇ lmorpholine, pyridine, ⁇ -picoline, ⁇ - picolinb ⁇ i v-p co I ⁇ e.
  • a phas Ie t irans er catalyst is used, when an inorganic base is used.
  • the PTC is selected from the group consis nit ⁇ ft! of z ⁇ hriethylammo ⁇ ium chloride, tetrabut ⁇ lar ⁇ r ⁇ o ⁇ ium bromide, tetrob ⁇ tylammonium hydrogeri lsulp ia1 e, 15 Crown 5 or 10 Crown 6.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

An objective of the present invention is to develop commercially viable methods for the synthesis of 5-[2-phenylsulfony)ethyl]-1H-indole of Formule (II), where R1 and R2 are same or different and each independently represent a hydrogen, fluorine, or di(lower alkyl)amino, acyl, or alkoxy carbonyl or chlorine atom, or a lower alkyl, lower alkoxy, nitro, cyano, aminolower alkylamine group Formula (II). Another objective of the present invention is to convert the product Formula (II) to Formula (I) in high yields, where R1 and R2 are same or different and each independently represent a hydrogen, fluorine, or di(lower alkyl)amino, acyl, or alkoxy carbonyl or chlorine atom, or a lower alkyl, lower alkoxy, nitro, cyano, aminolower alkylamine group Formula (I). One of the first processes attempted was by reacting the indole derivative of Formula (III) with aryl vinyl sulphones of Formula (V) as shown in Scheme-III. Another process attempted was by reacting the aniline derivative of Formula (VI) with aryl sulphones of Formula (VII) as shown in Scheme-III. Scheme IV.

Description

Title: 1 ! SψrtΗESlS OF NOVEL 5-(2-(PHENYLSULFONYL) ETHYL)-1H-INDOLE
DERϊVjpT bi
BACKriROUN Q = THE iNVENTlON:
The syfitfi .sis >f -[(2-phenyJsulfony)ethenyl]-lH-indole of formula II, is described in US6201131.
There areitwe examples describing the synthesis of the compound of formula Il
Exam es Tibes the process by the reaction of 5-bτomoiπdole (III) with the methyl sulfonyl derivative of f»enyfsuffonyj)ethanσl (IV). The process is given in scheme-! o /
^. -0V J)
Br' *^
IV m
Scheme-I
In this pH>ce< ;, 1 ie product is obtained in 23% yield.
r
Exempli jl3 f as described the synthesis by the reaction of 5-iodoindole (Ilia) with trifluoacetyl derivative of (2-bh.lW«s ilfi ιnyl)ethanol (IV) as represented in scheme Il
,CF3 «s ^^ J
\
o Il
IY ma IV
5cheme-ll
Usfngt^ls pr >cι ss, the product is obtained in about 5296 yield.
By bόttjlthe ne hods, yields of the required product are moderate to good.
5-[(2-pfti.nyl ul onyJethenyll-lH-iπdole (If) is an important building block in developing indole derivatives < f tt ierapcutic importance.
Hence there is in urgent requirement to achieve excellent yields of these types of indole derivatives SUMNJAάV O! Jl E INVENTION:
An obji»ctive < Ftl ie present Invention is to develop commercially viable methods for the synthesis of 5- [(2-phέπyisulf m) )ethyl]-lH-lndole of formula II,
Figure imgf000004_0001
where R1 and R2 arc the same QΓ different and each independently
represent a hydrogen, fluorine, or diflowcr αikyOamino, scyl, or
alkony caibβnyl or chlorine βom, or a lonπr nlkyl, lower aJkςBCV.
niito, cyaπσ, amiπolower alkylemmc group
Formula Il
Another!I biij j,efetife of the present invention is to convert the product formula Il to formula I in high yields.
Figure imgf000004_0002
where Tl1 and R2 ore tho same βr different and rarh independently
represent a hydrogen, fluorine, or di(lower altyl)ajnhio, aeyl, or
aϋcoxy carbonyl αr chlorine atom, or a loner alkyl, lower βJkoxy,
nitro. ι-ynnn, aminotσwer aHcylaminc group
Formula I
One of the ffrstl processes attempted was by reacting the indole derivative of formula III with aryl vinyl
I ' J l
sulphυries oqfojmula V as shown in Scheme-Ill .
Figure imgf000005_0001
Scheme-Ill
Another! brnφsfj attempted was by reacting the aniline derivative of formula Vl with aryl sulphones of formulaml aa sHown in Scheme-Ill.
Figure imgf000006_0001
Scheme-IV
III with aryl vinyl
Figure imgf000007_0001
Scheme-Ill a
Figure imgf000007_0002
The aryl v^nyl slulfbne is represented by formula V, given below
Figure imgf000008_0001
where R1 and R2 arc the same or different and each independently represent a hydrogen, fluorine, or diflower alkyl)amtflo, acyi, or alkoxy caibonyl or chlorine atom, or a lower atkyl, lower alkoxy, nitro. ryaππ, αminolσwer alkylamine group
Foπrnda-V
Figure imgf000008_0002
R5 is Acetyl, propyl, trlfluoacetyt,
fcbuftw rartooπyl, benzyloxy carbonyl or fluoroa/y, oxycartaonyl
Vl
is reacte'ijf wlψi sjn 2-aryl sulfonyloxy ethyl hatide of formula VII,
Figure imgf000008_0003
VII
whereiri IR1 ajid R2 are as described earlier, X is chlorine or bromine
Figure imgf000009_0001
Scheme-V
Figure imgf000009_0002
An orgbnit o in vganic base is used, wherein inorganic base is selected from the group consisting sod liiuuππil cirbo , potassium carbonate or cesium carbonate and the organic base is selected from the gro uupp toπs iiisstti ig of triethylamine, diisopropytethylamine, N-methγlmorpholine, pyridine, α-picoline, β- picolinb όi v-p co Iπe.
A phas Ie t irans er catalyst is used, when an inorganic base is used. The PTC is selected from the group consis nitπft! of zγhriethylammoπium chloride, tetrabutγlarπrπoπium bromide, tetrobυtylammonium hydrogeri lsulp ia1 e, 15 Crown 5 or 10 Crown 6.
The reaciron I eferably carried out at a temperature of 30 to 1500C, more preferably at 40-1300C and most preterab y 160-1200C.
On compitetlo per TLC monitoring, the reaction mixture is worked up to give the product of formula x I!
The product c Ffc rmula X Is converted to the product of formula Xl as per scheme VII
Figure imgf000010_0001
Fonniilfr-Xl
Figure imgf000010_0002
Scheme-VII
Figure imgf000010_0003
The proαuct
Figure imgf000010_0004
is hydrolyzed to the product formula I as represented in scheme-VIII
Figure imgf000011_0001
Scheme-VIH
Figure imgf000011_0002
EXAMPlifeS in the follow ng examples, the preferred embodiments of the present invention are described only by way of (llυst Ig the process of the invention. However, these do not limit the scope of the present fπvetiUc/n fn < rvy way.
Examplefl
Figure imgf000011_0003
Example-ll
Figure imgf000012_0001
Examples-Ill
N-(4-(2-tøher rts{jlfoπyl)ethyl)pheπy!)acetamide, VIII
20gm ofA-(2 _hl sroethylsυlfonyl) benzene in 125ml of dichloromethαne was cooled to S0C. 13gm of N- phenylacetan id ! was added to the reaction mixture and 55gm of anhydrous AlG3 was slowly added maintaining i he temperature of the reaction mixture at S0C- After completion of the reaction, the reaction1 imix ur > was quenched into 500ml of ice water containing hydrochloric acid. Separated dichlorσmetr an s was concentrated to give 7figm of N-(4-(2-(phenylsulfonγl)ethyl)phenyl)acetamide as waxy solid.
Examμl^lV
N-(2,2-dfeth( xy !thyl)-N-(4-(2-(phenylsυlfonyl)ethyl)phenyl)acetamide, X
10gm of|N-(' -(phenylsulfonyl)ethyl)phe«yl)acetamide was dissolved in 100ml of dimethyfformamide, 0.5gm of t« tπ butylammoniumbromide and 4gm of potassium carbonate added. 7.5gm of 2- bromoάletd Ji iyde diethyl βcctαl was added and temperature was raised to 65ήC After the reaction was cortiplet 3d the reaction mixture was filtered and filtrate added into 300ml of water. Product was extract*-! ir < lchtorompthane and concentrated to get llgm of N-(2,2-diethoxyethyl)-N-(4-(2- (pheny&ulfo tyl ethyf)pheπyl)acetamide.
Figure imgf000013_0001
obtained, N-aι^βt^l-S-{2-(ph*>nylsιilfoπvl)ethvl)-lH-iπdole 6.0gm, showed a melting point
Example^VI
5-(2-(Phenyis lf<jnyl)ethyl)-lH-tndo!e, I
5gm of sN-ac sty -5-(2-(phenylsulfonγl)ethyl)-lH-ϊndole was dissolved in 40ml αf ethanol and 1.5gm of potassium ca be nate added. The reaction was stirred at room temperature till the reaction complete, The reaction mi cture filtered and Nitrate concentrated under reduced pressure to give 4gm of 5-(7- (phenγlsiilfor !thyl)-lH-indole

Claims

novel 5-(2-(phenyl5ulfoπy()ethyl)-lH-ϊndole derivative of formula-l
Figure imgf000014_0001
Figure imgf000014_0002
to
of
Figure imgf000014_0003
ύ) rβict'Aig product of formufa-VlH with product of formuta-!X to get product of formυla-X same or amino,
Figure imgf000015_0001
6. ^s cl m id in claim Ib, wherein, catalytic hydrogeπation is carried out preferably in the pfresi of 10% pH/r..
7- As c !d in claim 2a, wherein, Fried el -Crafts reaction is carried In solvent selected from HhethΛ e chloride or dichloromethane, preferably dϊchloromethane
8. As cl m ;d in claim 2b, wherein, the reaction of product of formula VI(I with the product of form IX is carried out selected from aeetonitrile, N,N-dimethytformamϊrifi, N,N-dimethyl dceta e or N-methyl pyrrolidin-2-one in the presence of a base selected from sodium carbo e, potassium carbonate, cesium carbonate, triethyl amine, diisσpropyl ethylamine or N- meth rr orpholine, preferably in N,N-dimethγl formamide and potassium carbonate
9. As cl m id in claim 2c, wherein, the cyclizatlσn of the product of formula X to the product of form Xl Is carried out a reagent chosen from sulphuric acid, trifluoro acetatic acid or πγdi rch jric acid at 40βC to 100βC, preferably in sulphuric acid at 60-7(TC
10. As cl; m d in claim 2d, wherein, the conversion of the product of formula-X to formula-l is
έarrli ut a selected from methanol, ethanol, lsoproanol or n-butaπol in the presence of a base cted from sodium carbonate, potassium carbonate or cesium carbonate aτ 60-120"c, prefe y in ethanol containing potassium carbonate at 6O-80°C
PCT/IB2010/001886 2009-08-25 2010-07-30 Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives Ceased WO2011024039A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2030/CHE/2009 2009-08-25
IN2030CH2009 2009-08-25

Publications (1)

Publication Number Publication Date
WO2011024039A1 true WO2011024039A1 (en) 2011-03-03

Family

ID=43627318

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2010/001886 Ceased WO2011024039A1 (en) 2009-08-25 2010-07-30 Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives

Country Status (1)

Country Link
WO (1) WO2011024039A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006973A1 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
EP1088817A2 (en) * 1999-10-01 2001-04-04 Pfizer Limited Process for the preparation of 3-acyl-indoles
WO2002050063A1 (en) * 2000-12-20 2002-06-27 Pfizer Limited New process

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006973A1 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
EP1088817A2 (en) * 1999-10-01 2001-04-04 Pfizer Limited Process for the preparation of 3-acyl-indoles
WO2002050063A1 (en) * 2000-12-20 2002-06-27 Pfizer Limited New process

Similar Documents

Publication Publication Date Title
CN106061972B (en) 5-Fluoro-4-imino-3-(alkyl/substituted alkyl)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1H)-one and preparation method thereof
JP7728952B2 (en) Pharmaceutical processes and intermediates
CN108424395B (en) Preparation method of sulfentrazone
JP5689321B2 (en) Process for producing 2-amino-4-trifluoromethylpyridines
WO2011024039A1 (en) Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives
JP6197868B2 (en) Method for producing pyridazinone compound
CA3048084A1 (en) Protected oxadiazacyclic compounds, method for preparing oxadiazacyclic compounds and uses thereof
CN103387547B (en) A kind of method preparing phonetic mite amine
TW201002670A (en) Process for preparing substituted biphenylanilides
WO2011016228A1 (en) Method for producing 4,6-dialkoxy-2-cyanomethylpyrimidine and synthetic intermediate thereof
JP2009035508A (en) Process for producing optically active carboxylic acid
KR101686087B1 (en) Process for Production of Optically Active Indoline Derivatives or Salts Thereof
AU2006240772B2 (en) Method for producing nicotinic acid derivative or salt thereof
JP4418430B2 (en) Method for producing sulfonamide-containing indole compound
JP2011057575A (en) Manufacturing method of 4-hydroxybenzothiophene derivative
JP2009126785A (en) Method for producing 2-iodo-3,4-dimethoxybenzonitrile
JP2009126784A (en) A method for producing 2-iodo-3,4-dimethoxybenzonitrile.
US7122674B2 (en) Process for preparing high-purity hydroxyindolylglyoxylamides
JP2004010601A (en) Process for producing indole derivative and useful intermediate therefor
KR100566562B1 (en) Manufacturing method of sumatriptan
JP2011526257A (en) Process for producing N-phenyl-N- (4-piperidinyl) amide salt
KR102157528B1 (en) Method for producing 2-aminonicotinic acid benzyl ester derivative
JPH07316137A (en) Method for producing (hexahydro-1-methyl-1H-azepin-4-yl) -hydrazine or a salt thereof
JPWO2005063678A1 (en) Method for producing phenylacetic acid derivative
KR101152607B1 (en) Process for preparing 6-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-3-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10811331

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10811331

Country of ref document: EP

Kind code of ref document: A1